Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France

BACKGROUND: Current guidelines recommend intramuscular botulinum toxin type A (BoNT-A) injection as first-line treatment for spasticity, a frequent and impairing feature of various central nervous system (CNS) lesions such as stroke. Patients with spasticity commonly require BoNT-A injections once e...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Jonathan, Karam, Pierre, Forestier, Anne, Loze, Jean-Yves, Bensmail, Djamel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482253/
https://www.ncbi.nlm.nih.gov/pubmed/37681005
http://dx.doi.org/10.3389/fneur.2023.1245228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482253/
https://www.ncbi.nlm.nih.gov/pubmed/37681005
http://dx.doi.org/10.3389/fneur.2023.1245228

Ejemplares similares